TGF-beta resistant cytotoxic T-lymphocytes

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TGF-beta resistant cytotoxic T-lymphocytes, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC [Phase 1]

See pricing